Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Malaria as a Protection Factor Against Severe COVID-19 in the Democratic Republic of Congo (Palu-COVID)

NCT05012280 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT05012280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05012280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Malaria as a Protection Factor Against Severe COVID-19 in the Democratic Republic of Congo (Palu-COVID)
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Observational
Overall status
Terminated
Start date
September 4, 2021
Completion date
August 17, 2022
Enrollment
238 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, paludism